Stock listing

NASDAQ:KIN Kindred Biosciences Inc Stock

Follow Kindred Biosciences Inc into a list and get an email when it puts out news.

Last close · NASDAQ:KIN

$9.25 USD

Close on Aug 30, 2021 · No longer trades

Dec 12, 2013 to last close -22.6% · weekly closes, Dec 12, 2013 – Aug 30, 2021
Lowest – highest close
$3.15 – $26.50 USDSince Dec 12, 2013 · lowest Jan 25, 2016 · highest Feb 26, 2014

Delisted NASDAQ:KIN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:KIN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Kindred Biosciences Inc on 6ix

Decks
9 decks · latest Jun 16, 2021

Decks

DeckKindSlidesDate
Merger or Acquisition (June 2021)Merger or acquisition16 slidesJun 16, 2021
Investor Presentation (January 2020)Investor deck42 slidesJan 13, 2020
Investor Presentation (September 2018)Investor deck41 slidesSep 4, 2018
Investor Presentation (May 2018)Investor deck39 slidesMay 24, 2018
Investor Presentation (January 2017)Investor deck45 slidesJan 6, 2017
Investor Presentation (December 2016)Investor deck42 slidesDec 7, 2016
Investor Presentation (January 2016)Investor deck40 slidesJan 11, 2016
Investor Presentation (March 2015)Investor deck35 slidesMar 24, 2015
Investor Presentation (September 2014)Investor deck41 slidesSep 24, 2014

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Oleg Nodelman
Other companies: Theravance Biopharma, Inc. (BSFS · Since at least Nov 5, 2026); Aktis Oncology, Inc. (Director · Since at least Jan 8, 2026); Zymeworks Inc. (Director · Since at least Feb 17, 2025); AnaptysBio, Inc. (Member of the Nominating and Corporate Governance Committee · Since at least Apr 8, 2021); Nuvation Bio Inc. (Director · Jun 30, 2020 – Sep 19, 2023 · Past); Panacea Acquisition II Corp (Director · Apr 6, 2020 – Apr 28, 2023 · Past); Prothena Corporation plc (Director · Dec 3, 2019 – Dec 3, 2019 · Past)
Director · Dec 11, 2013 – Sep 29, 2014 · Past
Stephen S Galliker
Other companies: SELLAS Life Sciences Group, Inc. (Director · Feb 14, 2008 – Oct 10, 2017 · Past); Osteotech Inc (Director · Jun 21, 2006 – Nov 16, 2010 · Past); Dyax Corp (EVP and CFO · May 19, 2006 – Jul 16, 2008 · Past)
Chief Financial Officer · Dec 11, 2013 – Feb 3, 2014 · Past
Ernest Mario
Other companies: Hyperion DeFi, Inc. (Director · Jan 15, 2021 – Nov 17, 2021 · Past); Soleno Therapeutics, Inc. (Director · Oct 30, 2020 – Jun 6, 2024 · Past)
Director · Jan 20, 2021 – Jan 20, 2021 · Past
Richard Chin
Other companies: Cytek Biosciences, Inc. (Director · Since at least Jun 18, 2025)
Chief Executive Officer, Director · Jan 17, 2020 – Aug 27, 2021 · Past
Herbert D MontgomeryDirector · Apr 15, 2016 – Aug 27, 2021 · Past
Lyndon LienDirector · Feb 5, 2021 – Aug 27, 2021 · Past
Raymond TownsendDirector · Dec 11, 2013 – Aug 27, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about Kindred Biosciences Inc.